Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Curve Biosciences Raises $40M Led by Luma Group
Growth StageVenture Capital

Curve Biosciences Raises $40M Led by Luma Group

•October 29, 2025
•Oct 29, 2025
0

Participants

Curve Biosciences

Curve Biosciences

company

Luma

Luma

investor

First Spark Ventures

First Spark Ventures

investor

Techas Capital

Techas Capital

investor

Micah Spear

Micah Spear

investor

Civilization Ventures

Civilization Ventures

investor

LifeX

LifeX

investor

Merriam-Webster

Merriam-Webster

investor

Mintaka Ventures

Mintaka Ventures

investor

NZVC

NZVC

investor

Why It Matters

The infusion of $40 million positions Curve Biosciences to scale its whole-body intelligence technology, potentially reshaping preventive health and personalized medicine markets, while signaling strong venture confidence in AI‑driven biotech solutions.

Deal Summary

Curve Biosciences announced a $40M funding round led by Luma Group with participation from First Spark Ventures, Techas Capital, Micah Spear, Civilization Ventures, LifeX Ventures, Incite, Mintaka VC, NZVC and others. The financing was disclosed in a company announcement on October 29, 2025.

0

Comments

Want to join the conversation?

Loading comments...